N/A N=10 P400 for Stage II-IV Pressure Ulcers in Home and Extended Care
Pressure Ulcers
Primary: Change From Baseline in Ulcer Surface Area at Week 12 — -7.96 cm^2
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=21 Wound Management for Sacral Pressure Ulcers With Necrotic Tissue
Pressure Ulcers
Primary: Percentage of Wounds Healed — 63.1; 6.1 percentage of wounds
N/A N=60 Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries
Pressure Ulcers Stage III · Pressure Ulcer, Stage IV · Pressure Ulcer
Primary: Incidence of Complete Epithelialization — 2; 1; 0 No of wounds w/ complete epithelization
N/A N=80 Treatment of Pressure Ulcers Using Biological Skin Substitutes
Pressure Sore
Primary: Percent Change in Wound Area — -78.5; -65.1 percentage change
Phase 4 N=65 Pressure Ulcer Healing With Microcyn
Pressure Ulcer · Spinal Cord Injuries
Primary: Pressure Ulcer Size (Length x Width x Depth, cm^3) at Baseline — 10.13; 21.00 cm^3
N/A N=15 Effects of Different Support Surfaces on the Properties Skin After Loading
Pressure Ulcers
Primary: Transepidermal Water Loss (TEWL) in g/m2/h on Sacrum, at Baseline — 7.8; 7.7; 7.1 g/m2/h
N/A N=43 Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy
Open Wound Abdominal Wall · Wound Non Healing
Primary: Closure Rate of Non-healing Wounds — 45.79; 89.98 percentage of healing
N/A N=48 EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
Pressure Sore · Pressure Ulcer · Pressure Ulcers Stage III
Primary: Percentage Difference in PUSH Score — 23.1; 39.1 percentage reduction of PUSH score
N/A N=50 Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings
Pressure Incidence Prevention
Primary: User Friendliness of Both Sacrum and Heel (Left & Right) Dressings: Comfort, Conformability, Acceptability, the Handling at Application and Ease of Inspection of the…
N/A N=1,633 Silicone Adhesive Multilayer Foam Dressings to Prevent Pressure Ulcer
Pressure Ulcer
Primary: Number of Participants Who Developed a New Pressure Ulcer Category 2 or Worse on Sacrum, Heels or Greater Trochanter — 43; 34 Participants — p=0.04
N/A N=144 Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Pressure Ulcers · Spinal Cord Injuries
Primary: Percent of Possible Self-Reported Skin Care Behaviors — 73.8; 74.1; 83.5; 79.5 % of Possible Self-Reported Behaviors
N/A N=39 Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
Diabetic Foot Ulcers
Primary: Size of Index Wound Based on Calculations Wound Width x Length x Depth 2. Size of Index Wound Based on Calculations Wound Width x Length x Depth — 2.05; 3.33 mm^3
N/A N=359 Polyurethane Foam on the Sacrum for Prevention
Hip Fracture · Pressure Ulcer
Primary: Number of Participants With Pressure Sores — 8; 28 Participants
N/A N=12 Comparing the Effects of Three Different Dressings on the Cutaneous Response of Sacral Skin
Pressure Ulcer Prevention
Primary: Change in Skin Surface Temperature From Baseline — 3.1; 3.8; 3.0; 3.3 °C
Phase 4 N=29 A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration
Pressure Ulcer
Primary: Erythema ( No/Yes) — 5; 24; 16; 13 participants
N/A N=80 Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers
Pressure Ulcer
Primary: Percentage of Participants With Successful Closure of Wound at 2 Weeks After Surgery — 85.7142857; 87.5 percent of participants
N/A N=8 An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients
Donor Site Complication
Primary: Percentage of Participants Who Had > 95 % Epithelialization at Day 10 — 0 percentage of participants
N/A N=21 Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended
Pressure Ulcers
Primary: Number of Participants With Worsening in Peri-Skin Wound.(Maceration From Baseline to 6 Weeks) — 2 participants
Phase 2 N=28 Enhancement of Pressure Healing With Pulsatile Lavage
Spinal Cord Injury
Primary: Pressure Ulcer Geometry — 3.5; 4.9; 2.9; 3.0 cm
N/A N=258 Wheeled Mobility for Preventing Pressure Ulcers
Mobility Limitation
Primary: Incidence of a Sitting-induced Pressure Ulcer — 19; 15; 75; 69 Participants — p=0.77
N/A N=18 Developing a Home Telehealth Program to Manage Pressure Ulcers in SCI/D
Spinal Cord Injury
Primary: Days of Data — 9; 7 days
Phase 2 N=30 Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus
Diabetic Foot Infections
Primary: Number of Participants With Treatment-related Treatment-emergent Adverse Events as Graded According to the Common Terminology Criteria for Adverse Events v4.02 (CTCAE)…
N/A N=67 Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk
Pressure Injury Prevention
Primary: Number of Adverse Events — 0 Adverse events
Phase 2 N=90 Compression Device Versus 4-layer Compression System
Leg Ulcers
Primary: Safety Measured by the Number of Subjects With Adverse Events (Including Any Deterioration of Ulcer) — 33; 47 Number of Subjects with Adverse Events
N/A N=475 Effectiveness of Two Silicone Dressings for Sacral and Heel Pressure Ulcer Prevention
Pressure Ulcer
Primary: Number of Pressure Ulcers Category II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Proportion) — 6; 22 Pressure ulcer
N/A N=226 PriMatrix for the Management of Diabetic Foot Ulcers
Diabetic Foot Ulcer
Primary: Percentage of Subjects With Complete Wound Closure, as Assessed by the Investigator, at or Before Week 12 of the Treatment Phase — 47; 29 Participants
N/A N=32 Split Thickness Donor Site Healing With MIST Study
Burns · Trauma · Venous Ulcers
Primary: Rate of Wound Healing — 12.1; 21.3 Days
N/A N=24 Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot Ulcers
Diabetic Foot Ulcer
Primary: Percentage of Wound Area Reduction — 83.9; 71.3 Percentage of Wound Area Reduction
N/A N=104 Treatment of Full-Thickness Wounds: NPWT Combined With Type-I Collagen Based Advanced Skin Substitute Versus NPWT Alone
Full Thickness Skin Defects · Ulcer
Primary: Percentage Change in Wound Area — 23.73; 15.21; 34.47; 22.52 percentage change
N/A N=53 MIRODERM H2H DFU Study
Diabetic Foot Ulcer
Primary: Percentage of Participants — 57.89 Percentage of participants with healed u